AR111569A1 - Combinaciones de lisobactina y aminoglucósidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos - Google Patents

Combinaciones de lisobactina y aminoglucósidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos

Info

Publication number
AR111569A1
AR111569A1 ARP180100377A ARP180100377A AR111569A1 AR 111569 A1 AR111569 A1 AR 111569A1 AR P180100377 A ARP180100377 A AR P180100377A AR P180100377 A ARP180100377 A AR P180100377A AR 111569 A1 AR111569 A1 AR 111569A1
Authority
AR
Argentina
Prior art keywords
gram
diseases caused
human animals
lisobactin
aminoglucosids
Prior art date
Application number
ARP180100377A
Other languages
English (en)
Inventor
Wolfgang Wiehl
Gert Daube
Stefan Flker
Guido Schiffer
Johannes Kbberling
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of AR111569A1 publication Critical patent/AR111569A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Abstract

La presente se refiere a la combinación de lisobactina con un antibiótico aminoglucósido para su uso en el tratamiento de enfermedades causadas por bacterias Gram positivas y Gram negativas en animales no humanos. Particularmente la presente puede tratar la mastitis bovina.
ARP180100377A 2017-02-17 2018-02-16 Combinaciones de lisobactina y aminoglucósidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos AR111569A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17156737.3A EP3363452A1 (en) 2017-02-17 2017-02-17 Combinations of lysobactin and aminogylcosides against diseases caused by gram-positive and gram-negative bacteria in non-human animals

Publications (1)

Publication Number Publication Date
AR111569A1 true AR111569A1 (es) 2019-07-31

Family

ID=58098497

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180100377A AR111569A1 (es) 2017-02-17 2018-02-16 Combinaciones de lisobactina y aminoglucósidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos

Country Status (16)

Country Link
US (2) US20200230204A1 (es)
EP (2) EP3363452A1 (es)
JP (1) JP6655771B1 (es)
KR (1) KR102123599B1 (es)
CN (1) CN110234338A (es)
AR (1) AR111569A1 (es)
AU (1) AU2018222615B2 (es)
BR (1) BR112019017010A2 (es)
CA (1) CA3053608C (es)
ES (1) ES2893927T3 (es)
MX (1) MX2019009573A (es)
NZ (1) NZ755710A (es)
RU (1) RU2760008C2 (es)
TW (1) TWI783969B (es)
UY (1) UY37607A (es)
WO (1) WO2018149871A1 (es)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011312A (en) * 1975-06-25 1977-03-08 American Home Products Corporation Prolonged release drug form for the treatment of bovine mastitis
US4172138A (en) * 1977-03-23 1979-10-23 Rhodes Russell E Method and composition of matter for the treatment of dry cows for mastitis
CA1266247A (en) 1985-03-25 1990-02-27 Adrienne A. Tymiak Antibiotic prepared from lysobacter sp. sc 14,067
JPH01132600A (ja) 1987-11-17 1989-05-25 Shionogi & Co Ltd カタノシンａおよびｂならびにその製造法
DE10320781A1 (de) 2003-05-09 2004-11-25 Bayer Healthcare Ag Acylierte Nonadepsipeptide
US20050191270A1 (en) * 2004-02-27 2005-09-01 Hydromer, Inc. Anti-infectious hydrogel compositions
DE102004051023A1 (de) * 2004-10-20 2006-05-04 Bayer Healthcare Ag Desoxo-Nonadepsipeptide
DE102004051025A1 (de) 2004-10-20 2006-04-27 Bayer Healthcare Ag Substituierte Nonadepsipeptide
DE102004051024A1 (de) 2004-10-20 2006-04-27 Bayer Healthcare Ag Heterocyclyl-substituierte Nonadepsipeptide
DE102004053409A1 (de) 2004-11-05 2006-05-11 Bayer Healthcare Ag Verfahren zur gezielten Herstellung von Lysobactinfragmenten
DE102004053410A1 (de) 2004-11-05 2006-05-11 Bayer Healthcare Ag Cyclische Nonadepsipeptidamide
DE102004053407A1 (de) 2004-11-05 2006-05-11 Bayer Healthcare Ag Acylierte Nonadepsipeptide II
DE102006003443A1 (de) 2006-01-25 2007-07-26 Aicuris Gmbh & Co. Kg Asparagin-10-substituierte Nonadepsipeptide
DE102006018080A1 (de) 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Lysobactinamide
DE102006018250A1 (de) 2006-04-13 2007-10-18 Aicuris Gmbh & Co. Kg Verfahren zum Herstellen von cyclischen Depsipeptiden
ES2882063T3 (es) * 2012-12-03 2021-12-01 Novobiotic Pharmaceuticals Llc Nuevo depsipéptido y usos del mismo

Also Published As

Publication number Publication date
JP6655771B1 (ja) 2020-02-26
KR20190097293A (ko) 2019-08-20
RU2760008C2 (ru) 2021-11-22
CA3053608A1 (en) 2018-08-23
TW201834662A (zh) 2018-10-01
US20200230204A1 (en) 2020-07-23
EP3548059A1 (en) 2019-10-09
NZ755710A (en) 2022-04-29
CA3053608C (en) 2020-09-15
TWI783969B (zh) 2022-11-21
CN110234338A (zh) 2019-09-13
AU2018222615B2 (en) 2020-07-23
UY37607A (es) 2018-09-28
US20220000969A1 (en) 2022-01-06
WO2018149871A1 (en) 2018-08-23
EP3363452A1 (en) 2018-08-22
ES2893927T3 (es) 2022-02-10
RU2019129026A (ru) 2021-03-17
JP2020508299A (ja) 2020-03-19
KR102123599B1 (ko) 2020-06-16
AU2018222615A1 (en) 2019-08-08
MX2019009573A (es) 2019-10-02
RU2019129026A3 (es) 2021-03-17
EP3548059B1 (en) 2021-07-21
BR112019017010A2 (pt) 2020-04-14

Similar Documents

Publication Publication Date Title
BR112018005318A2 (pt) ?polipeptídeos de lisina ativos contra bactérias gram-negativas?
PE20191356A1 (es) Suministro de proteinas basado en bacterias con virulencia atenuada
SV2017005462A (es) Compuestos de isoxazol de ácido hidroxámico como inhibidores de lpxc
BR112018074133A2 (pt) composições de bacillus e métodos de uso com ruminantes
CL2019002135A1 (es) Células microbianas, métodos para producir las mismas, y usos de las mismas.
ECSP20084373A (es) Tiofencarboxamidas sustituidas y análogos de las mismas
MX2015014582A (es) Agentes para regulacion hacia abajo de la actividad y/o cantidad de bcl-xl y/o bcl-w.
BR112017009584A2 (pt) tratamento de retinite pigmentosa com n-acetilcisteína amida
AR109239A1 (es) Composiciones producidas por microorganismos con actividad estimuladora sobre las plantas
CO2018012180A2 (es) Métodos de tratamiento para enfermedades colestásicas y fibróticas
CO2017010271A2 (es) Archaebacteria en alimento para animales bioactivo, método para hacer la composición y métodos que emplean la composición
MX2015015127A (es) Enzimas para alimentacion animal.
PH12014501239A1 (en) Thymol and totarol antibacterial composition
AR095594A1 (es) Métodos para tratar infecciones en pacientes con sobrepeso y obesos usando antibióticos
AR111569A1 (es) Combinaciones de lisobactina y aminoglucósidos contra enfermedades causadas por bacterias gram positivas y gram negativas en animales no humanos
PE20190225A1 (es) Un metodo para reducir la contaminacion de huevo
BR112018067967A2 (pt) tratamento de pacientes com hipercolesterolemia familiar homozigótica por meio de terapia hipolipemiante
CO2019011305A2 (es) Tratamiento de una infección vaginal bacteriana
CO2019009216A2 (es) Asociación de n-acetilcisteína y colistina para su uso en infecciones bacterianas
BR112021026797A2 (pt) Composição alimentar para animais
ECSP18060284A (es) Tratamiento para microorganismos que contienen quitina
AR105047A1 (es) Métodos para el tratamiento de mujeres por el trastorno de deseo sexual hipoactivo (hsdd) con un tratamiento de combinación de bupropion y trazodona
CL2021001748A1 (es) Nueva vacuna
BR112016030962A2 (pt) uso de inibidores de metaloproteinase contra infecções bacterianas
AR109786A1 (es) Método para reducir el mal olor